Efficacy of pitavastatin alone and in combination with ezetimibe on lipid profile in type II diabetes patients on biguanide therapy.

Efficacy of pitavastatin alone and in combination with ezetimibe on lipid profile in type II diabetes patients on biguanide therapy. - Efficacy of pitavastatin alone and in combination with ezetimibe on lipid profile in type II diabetes patients on biguanide therapy.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047286

Enrollment

Registered

2023-06-01

Start date

2022-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyper(dys)lipidemia

Interventions

Patients taking metformin 500 mg BD Patients taking metformin 500 mg BD, pitavastatin 4 mg OD Patients taking metformin 500 mg BD, pitavastatin 2 mg OD and ezetimibe 10 mg OD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c>6.5%;patients on biguanide therapy; hyperlipidemia/dyslipidemia according to AHA guidelines; 30-65 years; both genders.

Exclusion criteria

Exclusion criteria: Pregnancy & lactation; patients on other drugs for diabetes type II or insulin; over 65 years of age; on antibiotics, calcium channel blockers or thyroxine; CKD,CLD or thyroid disease.

Design outcomes

Primary

Measure	Time frame
Identification of effective lipid inhibitor(s) therapy in type II diabetics on biguanides.	—

Secondary

Measure	Time frame
Correlation between glycemic and lipid parameters and groups of drugs	—

Countries

Asia(except Japan)

Contacts

Public ContactZehra Raza

Bahria University Bahria University of Health Sciences

ghazalraza24@gmail.com+923212477464

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026